NCT05468359: An ongoing trial by St. Jude Children's Research Hospital
This trial is ongoing. It must report results 7 years, 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05468359 |
|---|---|
| Title | ANGIO-A: Safety and Tolerability of Oral Cyclophosphamide and Sorafenib With Intravenous Bevacizumab With the Addition of Atezolizumab in Pediatric Solid Tumor Patients |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 7, 2022 |
| Completion date | June 30, 2032 |
| Required reporting date | June 30, 2033, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |